7 Reasons To Choose CLIA Kits For High-Sensitivity Immunoassays
By opting for CLIA kits, you’re not just choosing a [...]
Precisio Biotix Therapeutics, Inc. Announces Dosing of a 1st Patient with ClyO (Staph Lysin) to Treat a Multi Drug-Resistant Prosthetic Joint Infection
The FDA approved this treatment under a compassionate.
Orphalan Partners with MAP International and the Wilson Disease Association to Provide Life-Changing Medicine to Underserved Communities
Through this partnership, Orphalan will donate a supply of Cuvrior® [...]
Initiation of Commercialization of ProNephro AKI (NGAL) for Diagnostic Use in the US
This purchase order is to service US hospitals through BioPorto’s [...]
ACIP Recommends Use of Merck’s ENFLONSIA for Prevention of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season
ENFLONSIA is the first and only RSV preventive option for [...]
Breakthrough in Patient-Derived Stem Cells for Therapeutic Regenerative Medicine
These studies shed light on the scientific controversy of whether [...]
Alithea Genomics Launches MERCURIUS™ Total DRUG-seq: A Next-Generation Full-Length Transcriptome Profiling Platform for High-Throughput Compound Screening and Target Validation
“MERCURIUS Total DRUG-seq represents a new frontier in transcriptome-scale compound [...]
1Elevan Biopharmaceuticals Announces the Development of Its Next-Generation Peptide Therapeutics Headquarters in Fishers, Indiana
The new 133,500-square-foot headquarters at 12001 Exit 5 Parkway will [...]
Caliway Biopharmaceuticals Announces Successful EOP2 Meeting with the FDA for CBL-514 in Reduction of Abdominal Subcutaneous Fat
Caliway has completed the End-of-Phase 2 (EOP2) meeting with the [...]
Neogap Therapeutics Selected for EIC Soft-landing Programme in Boston
The EIC Soft-landing Programme provides business development support and opportunities [...]